110 related articles for article (PubMed ID: 10923696)
21. Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice.
Hunter JM; Cirrito JR; Restivo JL; Kinley RD; Sullivan PM; Holtzman DM; Koger D; Delong C; Lin S; Zhao L; Liu F; Bales K; Paul SM
Brain Res; 2012 Jul; 1467():120-32. PubMed ID: 22682924
[TBL] [Abstract][Full Text] [Related]
22. Valacyclovir treatment ameliorates the persistently increased pentylenetetrazol-induced seizure susceptibility in mice with herpes simplex virus type 1 infection.
Wu HM; Liang YC; Chen SH; Huang CC; Chen SH; Tsai JJ; Hsieh CL; Hsu KS
Exp Neurol; 2004 Sep; 189(1):66-77. PubMed ID: 15296837
[TBL] [Abstract][Full Text] [Related]
23. Reduced susceptibility to induced seizures in the Neuroligin-3(R451C) mouse model of autism.
Hill-Yardin EL; Argyropoulos A; Hosie S; Rind G; Anderson P; Hannan AJ; O'Brien TJ
Neurosci Lett; 2015 Mar; 589():57-61. PubMed ID: 25592157
[TBL] [Abstract][Full Text] [Related]
24. "Not just right experiences" in patients with Tourette syndrome: complex motor tics or compulsions?
Neal M; Cavanna AE
Psychiatry Res; 2013 Dec; 210(2):559-63. PubMed ID: 23850205
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of Executive Functioning in a Small Sample of Children With Tourette Syndrome.
Schwam DM; King TZ; Greenberg D
Appl Neuropsychol Child; 2015; 4(4):297-308. PubMed ID: 25495678
[TBL] [Abstract][Full Text] [Related]
26. LRP12 silencing during brain development results in cortical dyslamination and seizure sensitization.
Grote A; Robens BK; Blümcke I; Becker AJ; Schoch S; Gembé E
Neurobiol Dis; 2016 Feb; 86():170-6. PubMed ID: 26639854
[TBL] [Abstract][Full Text] [Related]
27. Anticonvulsant and neuroprotective effects of apelin-13 on pentylenetetrazole-induced seizures in male rats.
Kalantaripour TP; Esmaeili-Mahani S; Sheibani V; Asadi-Shekaari M; Pasban-Aliabadi H
Biomed Pharmacother; 2016 Dec; 84():258-263. PubMed ID: 27664950
[TBL] [Abstract][Full Text] [Related]
28. Motor and behavioral phenotype in conditional mutants with targeted ablation of cortical D1 dopamine receptor-expressing cells.
Jiang L; O'Leary C; Kim HA; Parish CL; Massalas J; Waddington JL; Ehrlich ME; Schütz G; Gantois I; Lawrence AJ; Drago J
Neurobiol Dis; 2015 Apr; 76():137-158. PubMed ID: 25684539
[TBL] [Abstract][Full Text] [Related]
29. Clinical phenomenology and phenotype variability in Tourette syndrome.
Grados MA; Mathews CA
J Psychosom Res; 2009 Dec; 67(6):491-6. PubMed ID: 19913653
[TBL] [Abstract][Full Text] [Related]
30. Tourette Syndrome and Chronic Tic Disorders: The Clinical Spectrum Beyond Tics.
Martino D; Ganos C; Pringsheim TM
Int Rev Neurobiol; 2017; 134():1461-1490. PubMed ID: 28805580
[TBL] [Abstract][Full Text] [Related]
31. Tourette syndrome in a longitudinal perspective. Clinical course of tics and comorbidities, coexisting psychopathologies, phenotypes and predictors.
Groth C
Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619935
[TBL] [Abstract][Full Text] [Related]
32. Octreotide ameliorates inflammation and apoptosis in acute and kindled murine PTZ paradigms.
Al-Shorbagy MY; Nassar NN
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):61-68. PubMed ID: 27695956
[TBL] [Abstract][Full Text] [Related]
33. Uric acid is released in the brain during seizure activity and increases severity of seizures in a mouse model for acute limbic seizures.
Thyrion L; Raedt R; Portelli J; Van Loo P; Wadman WJ; Glorieux G; Lambrecht BN; Janssens S; Vonck K; Boon P
Exp Neurol; 2016 Mar; 277():244-251. PubMed ID: 26774005
[TBL] [Abstract][Full Text] [Related]
34. Behavioral fragmentation in the D1CT-7 mouse model of Tourette's syndrome.
Santangelo A; Bortolato M; Mosher LJ; Crescimanno G; Di Giovanni G; Cassioli E; Ricca V; Casarrubea M
CNS Neurosci Ther; 2018 Aug; 24(8):703-711. PubMed ID: 29314714
[TBL] [Abstract][Full Text] [Related]
35. Effects of cerebellar stimulation on cortical and limbic seizure discharges [proceedings].
Kitamura M; Yamamoto T; Katayama Y; Nishimoto H; Tsubokawa T; Moriyasu N
Appl Neurophysiol; 1979; 42(5):306. PubMed ID: 518058
[No Abstract] [Full Text] [Related]
36. An introduction to the clinical phenomenology of Tourette syndrome.
Martino D; Madhusudan N; Zis P; Cavanna AE
Int Rev Neurobiol; 2013; 112():1-33. PubMed ID: 24295616
[TBL] [Abstract][Full Text] [Related]
37. Selective Silencing of Hippocampal Parvalbumin Interneurons Induces Development of Recurrent Spontaneous Limbic Seizures in Mice.
Drexel M; Romanov RA; Wood J; Weger S; Heilbronn R; Wulff P; Tasan RO; Harkany T; Sperk G
J Neurosci; 2017 Aug; 37(34):8166-8179. PubMed ID: 28733354
[TBL] [Abstract][Full Text] [Related]
38. Imaging the neural substrates involved in the genesis of pentylenetetrazol-induced seizures.
Brevard ME; Kulkarni P; King JA; Ferris CF
Epilepsia; 2006 Apr; 47(4):745-54. PubMed ID: 16650141
[TBL] [Abstract][Full Text] [Related]
39. Sensory phenomena related to tics, obsessive-compulsive symptoms, and global functioning in Tourette syndrome.
Kano Y; Matsuda N; Nonaka M; Fujio M; Kuwabara H; Kono T
Compr Psychiatry; 2015 Oct; 62():141-6. PubMed ID: 26343478
[TBL] [Abstract][Full Text] [Related]
40. Erdosteine ameliorates PTZ-induced oxidative stress in mice seizure model.
Ilhan A; Aladag MA; Kocer A; Boluk A; Gurel A; Armutcu F
Brain Res Bull; 2005 May; 65(6):495-9. PubMed ID: 15862921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
